Company Overview of KAHR medical Ltd.
KAHR medical, Ltd. develops fusion protein pharmaceuticals for the treatment of autoimmune diseases. The company’s drugs include KAHR-101 and KAHR-102 that are used for the treatment of psoriasis and rheumatoid arthritis. The company was founded in 2005 and is based in Jerusalem, Israel.
Hadassah Medical Center
Founded in 2005
972 4 629 2112
972 4 629 2112
Key Executives for KAHR medical Ltd.
Similar Private Companies By Industry
|Abital Pharma Pipelines Ltd.||Middle East/Africa|
|Active PX Ltd.||Middle East/Africa|
|Advanced Inhalation Technology Ltd.||Middle East/Africa|
|AIT Therapeutics, Inc.||Middle East/Africa|
|Angio B Ltd.||Middle East/Africa|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact KAHR medical Ltd., please visit www.kahr-medical.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.